Health Care & Hospital Law
May 10, 2022
Stanford expert testifies against drugmakers, stores
On cross-examination, Morgan, Lewis & Bockius LLP partner Wendy West Feinstein pointed out a publication by Lembke that advocated for pre-screening of patients for whom chronic opioid treatment is being considered.
A professor of psychiatry at Stanford took the stand as an expert witness Monday on behalf of the City of San Francisco to challenge the narrative of pharmaceutical companies and drugstores that failed addiction pre-screening by doctors was a key component of the opioid crisis.
During her 30-minute opening presentation, Dr. Anna Lembke testified, “Even though theoretically it’s possible, in practice, there are no validated screening tools ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In